HYTRIN
LOE ApproachingNDAORALTABLET
Approved
Aug 1987
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
1
Data completeness
2/8 — Basic
Drug data last refreshed 2d ago · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
HYTRIN is an oral tablet small-molecule NDA approved in 1987 by Abbott for benign prostatic hyperplasia and Parkinson's disease. The mechanism of action and pharmacologic class are not specified in available data. It is formulated as an oral tablet for systemic delivery.
LOE Approaching
Product is approaching loss of exclusivity with limited linked commercial job opportunities (3 positions), suggesting a mature, stable team focused on defending market share against generic and competitive pressures.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Clinical Trials (1)
FLOMAX® Versus HYTRIN® in Patients With the Signs and Symptoms of Benign Prostatic Hyperplasia
Started Aug 1998
1,993 enrolled
Prostatic Hyperplasia
Career Relevance
Only 3 linked positions exist for HYTRIN, reflecting a mature product with a compact team focused on manufacturing, regulatory compliance, and commercial defense. Roles emphasize operational efficiency and cost management rather than growth or innovation.
Sr. Analytical Chemist
Worked on HYTRIN at Abbott? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.